NCT06544265 2026-04-14SynKIR-310 for Relapsed/Refractory B-NHLVerismo TherapeuticsPhase 1 Recruiting36 enrolled
NCT02315612 2026-03-24Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed134 enrolled